fbpx

molecules of the month

daridorexant

dual orexin receptor GPCR antagonist

Ph. III efficacy for insomnia, oral 25-50 mg

from optimization of prior clinical candidate

ChemMedChem., Oct. 28, 2020

Idorsia Pharmaceuticals, Allschwil, CH

Structure of Daridorexant, an oral dual-orexin receptor antagonist (DORA)
1 min read

Idorsia clinical dual orexin receptor GPCR antagonist


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: